Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TNG

Transgene (TNG)

Transgene SA
Date:
Sort by:
 Showing the most relevant articles for your search:EU:TNG
DateTimeSourceHeadlineSymbolCompany
06/03/20241:30AMGlobeNewswire Inc.Transgene – Premier patient inclus dans la partie Phase II de l’étude randomisée de Phase I/II de son actif phare TG4050, un vaccin thérapeutique individualisé évalué dans les cancers de la tête et du couEU:TNGTransgene SA
06/03/20241:30AMGlobeNewswire Inc.Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck CancerEU:TNGTransgene SA
06/03/20241:30AMGlobeNewswire Inc.Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck CancerEU:TNGTransgene SA
05/15/202411:45AMGlobeNewswire Inc.Transgene’s Combined General Meeting of May 15, 2024EU:TNGTransgene SA
05/15/202411:45AMGlobeNewswire Inc.Transgene’s Combined General Meeting of May 15, 2024EU:TNGTransgene SA
05/15/202411:45AMGlobeNewswire Inc.Assemblée Générale Mixte de Transgene du 15 mai 2024EU:TNGTransgene SA
05/14/202411:45AMGlobeNewswire Inc.Transgene provides business and financial update for Q1 2024EU:TNGTransgene SA
05/14/202411:45AMGlobeNewswire Inc.Transgene provides business and financial update for Q1 2024EU:TNGTransgene SA
05/14/202411:45AMGlobeNewswire Inc.Transgene fait le point sur ses activités et sa situation financière au premier trimestre 2024EU:TNGTransgene SA
04/24/202411:45AMGlobeNewswire Inc.Mise à disposition des documents préparatoires à l'Assemblée générale du 15 mai 2024EU:TNGTransgene SA
04/24/202411:45AMGlobeNewswire Inc.Availability of Preparatory Documents for the Combined General Meeting of May 15, 2024EU:TNGTransgene SA
04/24/202411:45AMGlobeNewswire Inc.Availability of Preparatory Documents for the Combined General Meeting of May 15, 2024EU:TNGTransgene SA
04/11/20241:05PMGlobeNewswire Inc.Document d'enregistrement Universel 2023EU:TNGTransgene SA
04/11/202411:45AMGlobeNewswire Inc.MIse à disposition du document d'enregistrement universel 2023 de TransgeneEU:TNGTransgene SA
04/11/202411:45AMGlobeNewswire Inc.Availability of Transgene's 2023 Universal Registration DocumentEU:TNGTransgene SA
04/09/202411:45AMGlobeNewswire Inc.Transgene et NEC présentent les premiers signes de bénéfice clinique de leur vaccin individualisé contre le cancer, TG4050, dans les cancers de la tête et du cou à l’AACR 2024EU:TNGTransgene SA
04/09/202411:45AMGlobeNewswire Inc.Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024EU:TNGTransgene SA
04/09/202411:45AMGlobeNewswire Inc.Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024EU:TNGTransgene SA
03/27/202412:45PMGlobeNewswire Inc.Transgene prévoit des avancées significatives sur son portefeuille d’immunothérapies en 2024 et étend sa visibilité financière jusqu’au 4ème trimestre 2025EU:TNGTransgene SA
03/27/202412:45PMGlobeNewswire Inc.Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025EU:TNGTransgene SA
03/27/202412:45PMGlobeNewswire Inc.Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025EU:TNGTransgene SA
03/27/202412:45PMGlobeNewswire Inc.Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human Resources OfficerEU:TNGTransgene SA
03/27/202412:45PMGlobeNewswire Inc.Transgene nomme Lucie Larguier en tant que Directrice Financière et Christelle Schwoerer Comme Directrice des Ressources HumainesEU:TNGTransgene SA
03/27/202412:45PMGlobeNewswire Inc.Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human Resources OfficerEU:TNGTransgene SA
03/18/202412:45PMGlobeNewswire Inc.Transgene Announces Upcoming Investor MeetingsEU:TNGTransgene SA
03/18/202412:45PMGlobeNewswire Inc.Transgene annonce ses prochaines rencontres avec les investisseursEU:TNGTransgene SA
03/18/202412:45PMGlobeNewswire Inc.Transgene Announces Upcoming Investor MeetingsEU:TNGTransgene SA
03/06/20241:30AMGlobeNewswire Inc.Transgene to Present New Data on TG4050, an Individualized Cancer Vaccine, at AACR 2024EU:TNGTransgene SA
03/06/20241:30AMGlobeNewswire Inc.Transgene to Present New Data on TG4050, an Individualized Cancer Vaccine, at AACR 2024EU:TNGTransgene SA
03/06/20241:30AMGlobeNewswire Inc.Transgene présentera de nouvelles données sur son vaccin individualisé TG4050 à l’AACR 2024EU:TNGTransgene SA
 Showing the most relevant articles for your search:EU:TNG

Your Recent History

Delayed Upgrade Clock